{"id":231595,"date":"2026-09-07T15:21:56","date_gmt":"2026-09-07T09:51:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=231595"},"modified":"2026-09-07T15:21:57","modified_gmt":"2026-09-07T09:51:57","slug":"is-sun-pharma-advanced-research-company-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-sun-pharma-advanced-research-company-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Sun Pharma Advanced Research Company a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"

Sun Pharma Advanced Research Company share price around Rs 201. 30.4% below 52-week high of Rs 289. Q1 FY27 revenue Rs 64 crore, up 238.6% YoY. loss of Rs 21 crore. PE 4x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Sun Pharma Advanced Research Company continued to report a net loss in Q1 FY27, at Rs 21 crore, though the loss narrowed year on year as revenue grew to Rs 64 crore. The Sun Pharma Advanced Research Company share price near Rs 201 reflects a business still working toward profitability, so this is best treated as a turnaround watch rather than a value buy on this quarter’s numbers.<\/p>\n<\/div>\n

The Sun Pharma Advanced Research Company share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Sun Pharma Advanced Research Company is a drug discovery and research entity affiliated with the Sun Pharma group, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 64 crore, up 238.6% year on year, while the company reported a net loss of Rs 21 crore. That combination of numbers is exactly what this article breaks down, along with what it means for the Sun Pharma Advanced Research Company share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Sun Pharma Advanced Research Company share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n